Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK stroke campaign results suggest clear market push-pull impact

This article was originally published in Clinica

Executive Summary

A campaign to raise awareness in the UK of the symptoms of stroke and the importance of rapid medical intervention has resulted in a 70% rise in the number of stroke-related calls to the emergency services, the Department of Health (DH) announced today. The news provides an insight into the type of push-pull impact that public awareness can have on key medtech sectors. The campaign, launched in February, sought to address one of the aims of the national stroke plan, which also features better access to diagnostic imaging and therapeutic interventions.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044691

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel